Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis.
Ke ShiYao LiuXiaojing WangYuxin LiQun ZhangYing HuChongping RanYunyi HuangJie HouXian-Bo WangPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
FZHY combined with NAs was associated with a significantly lower risk of HCC than NAs alone in patients with HBC, which supports the integration of FZHY with antiviral treatment into clinical practice.
Keyphrases